Palvella Therapeutics, Inc. — Form D

Palvella Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-03. The offering totals $45.0M, of which $45.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-06-03
• Form: D
• Accession: 0001742961-20-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $45.0M
• Amount sold: $45.0M
• Investors: 48
• Date of first sale: 2020-05-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-368196

Issuer

• Name: Palvella Therapeutics, Inc.
• CIK: 0001742961
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 125 STRAFFORD AVENUE STE 360, WAYNE, PA, 19087
• Phone: 484-253-1461

Officers, directors & promoters (25)

Other filings by this issuer (4)

More

• CIK 1742961 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search